Adial Pharmaceuticals (ADIL) News Today $0.96 -0.08 (-7.69%) Closing price 01/17/2025 03:59 PM EasternExtended Trading$0.98 +0.03 (+2.60%) As of 08:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Adial Pharmaceuticals files to sell 5.0M shares of common stock for holdersDecember 21, 2024 | markets.businessinsider.comAdial granted U.S. patent for treatment of alcohol, drug dependenceDecember 3, 2024 | markets.businessinsider.comEXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype CombinationsDecember 3, 2024 | finance.yahoo.comAdial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype CombinationsDecember 3, 2024 | globenewswire.comAdial Pharmaceuticals Advances AD04 with Promising Study ResultsNovember 19, 2024 | markets.businessinsider.comMaxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)November 16, 2024 | markets.businessinsider.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | finanznachrichten.deAdial Pharmaceuticals (NASDAQ:ADIL) Stock, Short Interest ReportNovember 15, 2024 | benzinga.comEXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use DisorderNovember 15, 2024 | finance.yahoo.comAdial Pharmaceuticals initiated with a Buy at Rodman & RenshawNovember 15, 2024 | markets.businessinsider.comRodman & Renshaw Initiates Coverage of Adial Pharmaceuticals (ADIL) with Buy RecommendationNovember 15, 2024 | msn.comAdial Pharmaceuticals expects cash to fund operations into second half of 2025November 13, 2024 | markets.businessinsider.comAdial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | markets.businessinsider.comAdial Pharmaceuticals Approves Strategic Changes at Annual MeetingNovember 13, 2024 | markets.businessinsider.comAdial Pharmaceuticals Appoints New Chief Financial OfficerNovember 6, 2024 | markets.businessinsider.comAdial Pharmaceuticals Appoints Vinay Shah as Chief Financial OfficerNovember 5, 2024 | globenewswire.comAdial Pharmaceuticals to Present at the 2024 ThinkEquity ConferenceOctober 23, 2024 | globenewswire.comEXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder CandidateOctober 18, 2024 | finance.yahoo.comAdial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of RecoveryOctober 16, 2024 | finance.yahoo.comAdial Pharmaceuticals (NASDAQ:ADIL) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comMaxim Group Keeps Their Hold Rating on Adial Pharmaceuticals (ADIL)September 21, 2024 | markets.businessinsider.comAdial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderSeptember 19, 2024 | globenewswire.comAdial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | finanznachrichten.deAdial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | globenewswire.comADIL Stock Earnings: Adial Pharmaceuticals Reported Results for Q2 2024August 14, 2024 | markets.businessinsider.comAdial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04August 13, 2024 | finance.yahoo.comEXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use DisorderAugust 13, 2024 | msn.comBone Therapeutics SA (BT1.SG)August 10, 2024 | sg.finance.yahoo.comEXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4August 7, 2024 | msn.comAdial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderAugust 7, 2024 | globenewswire.comAdial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044July 31, 2024 | globenewswire.com3 Penny Stocks to Watch Now, 7/25/24July 25, 2024 | msn.comWhy Is Adial Pharmaceuticals (ADIL) Up 61% Today?July 23, 2024 | investorplace.comAdial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderJuly 23, 2024 | globenewswire.comADIL Stock Earnings: Adial Pharmaceuticals Beats EPS for Q4 2023June 27, 2024 | investorplace.comAdial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use DisorderJune 20, 2024 | globenewswire.comMillionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025June 5, 2024 | investorplace.comAdial CEO to Present at the Spring MicroCap Rodeo Conference on June 6thMay 29, 2024 | globenewswire.comADIL Stock Earnings: Adial Pharmaceuticals Misses EPS for Q1 2024May 15, 2024 | msn.comAdial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 15, 2024 | globenewswire.comAdial Pharmaceuticals secures new addiction treatment patentApril 24, 2024 | uk.investing.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeApril 22, 2024 | finanznachrichten.deEXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US PatentApril 22, 2024 | benzinga.comAdial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeApril 22, 2024 | globenewswire.comWhy Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars TodayApril 11, 2024 | msn.comDow Falls Over 1%; US Inflation Rate Accelerates In MarchApril 11, 2024 | msn.comAdial Pharmaceuticals Shares Rise 78% After Positive Trial Data for AD04April 10, 2024 | marketwatch.comAdial stock rallies 81% on data for alcohol abuse drugApril 10, 2024 | msn.comWhy Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today?April 10, 2024 | investorplace.com Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address ADIL Media Mentions By Week ADIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADIL News Sentiment▼1.000.49▲Average Medical News Sentiment ADIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADIL Articles This Week▼01▲ADIL Articles Average Week Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Enlivex Therapeutics News BioAtla News Lipocine News Pluri News Equillium News Forte Biosciences News Cyclo Therapeutics News Pulmatrix News NextCure News Marker Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADIL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADIL Stock Alerts